Elizabeth Shea | AbbVie, Inc. |
Richard A. Gonzalez | AbbVie, Inc. |
Michael E. Severino, M.D. | AbbVie, Inc. |
William J. Chase | AbbVie, Inc. |
Jami Rubin | Goldman Sachs & Co. LLC |
Joshua Schimmer | Evercore, Inc. |
Jason M. Gerberry | Bank of America Merrill Lynch |
Steve Scala | Cowen & Co. LLC |
Christopher Schott | JPMorgan Securities LLC |
Geoffrey Meacham | Barclays Capital, Inc. |
Gregg Gilbert | Deutsche Bank Securities, Inc. |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
David R. Risinger | Morgan Stanley & Co. LLC |
Good morning and thank you for standing by. Welcome to the AbbVie first quarter 2018 earnings conference call. All participants will be able to listen only until the question-and-answer portion of this conference. I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.